pharmaceutical investing Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 18h
pharmaceutical investing U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility 20 April
pharmaceutical investing Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders 09 April
